Acute Lymphoblastic Leukaemias (ALL) Completed Phase 1 / 2 Trials for Clofarabine (DB00631)

Also known as: Acute Lymphoblastic Leukemias / Acute Leukemia, Lymphoblastic / Acute Lymphoblastic Leukaemia / Acute Lymphoblastic Leukemia / Leukemia, Lymphoblastic, Acute / Lymphoblastic Leukemia, Acute / Leukemia, Acute Lymphoblastic / Leukaemia, Lymphoblastic, Acute / Acute Lymphoblastic Leukemia (ALL) / Leukemia, Lymphoblastic,Acute / Acute Leukaemia, Lymphoblastic / Acute lymphoblastic leukemia with failed remission / Leukemia lymphoblastic acute / Lymphoid leukaemia, acute / Acute lymphoid leukaemia / Lymphoid leukemia, acute / Acute lymphoid leukemia / ALL / Leukaemia lymphoblastic acute / Acute lymphocytic leukemia / Acute lymphatic leukaemia / Leukaemias acute lymphocytic / Acute lymphatic leukemia / Acute lymphocytic leukaemia

IndicationStatusPhase
DBCOND0073466 (Acute Lymphoblastic Leukaemias (ALL))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00315705A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.Treatment
NCT00412243Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia PatientsTreatment
NCT00529360Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALLTreatment